LON:PRM - Proteome Sciences Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
GBX 2.59 0.00 (0.00 %)
(As of 02/19/2019 04:00 PM ET)
Previous CloseGBX 2.59
Today's RangeGBX 2.63 - GBX 2.63
52-Week RangeGBX 2.61 - GBX 5.64
Volume3,696 shs
Average Volume88,695 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers. It delivers content for personalized medicine in the areas of biomarker services, isobaric reagents, and biomarkers. The company designs, performs, and interprets high resolution proteomics studies to improve target discovery, validation, and mechanism of action studies; offers specialized services to enhance discovery and validation of mechanistic biomarkers in peripheral fluids; and provides a set of bioinformatics tools to enhance data integration, and select regulated features and map to biological processes. It primarily serves pharmaceutical companies and other sectors, including academic research. The company was incorporated in 1993 and is headquartered in London, the United Kingdom.

Receive PRM News and Ratings via Email

Sign-up to receive the latest news and ratings for PRM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Laboratories & Research



Sales & Book Value

Annual SalesN/A



OptionableNot Optionable

Proteome Sciences (LON:PRM) Frequently Asked Questions

What is Proteome Sciences' stock symbol?

Proteome Sciences trades on the London Stock Exchange (LON) under the ticker symbol "PRM."

What price target have analysts set for PRM?

0 brokerages have issued 1-year target prices for Proteome Sciences' shares. Their predictions range from GBX 7 to GBX 7. On average, they anticipate Proteome Sciences' share price to reach GBX 7 in the next year. This suggests a possible upside of 170.3% from the stock's current price. View Analyst Price Targets for Proteome Sciences.

Has Proteome Sciences been receiving favorable news coverage?

News headlines about PRM stock have trended somewhat positive recently, InfoTrie reports. InfoTrie scores the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Proteome Sciences earned a coverage optimism score of 0.9 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 4.0 out of 10, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

Who are some of Proteome Sciences' key competitors?

Some companies that are related to Proteome Sciences include VolitionRX (VNRX), Spectral Medical (EDT), ANGLE (AGL), DiaSorin (DIA), Polarityte (COOL) and Premaitha Health (NIPT).

Who are Proteome Sciences' key executives?

Proteome Sciences' management team includes the folowing people:
  • Dr. Jeremy Rupert Michael Haigh, CEO & Exec. Director (Age 58)
  • Dr. Ian H. Pike, Chief Scientific Officer & Exec. Director
  • Mr. Stefan Fuhrmann, Interim Fin. Director
  • Dr. Josef Schwarz, Chief Compliance Officer
  • Mr. Glenn Barney, VP of Sales & Marketing

How do I buy shares of Proteome Sciences?

Shares of PRM and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Proteome Sciences' stock price today?

One share of PRM stock can currently be purchased for approximately GBX 2.59.

What is Proteome Sciences' official website?

The official website for Proteome Sciences is http://www.proteomics.com/.

How can I contact Proteome Sciences?

Proteome Sciences' mailing address is Hamilton House, Mabledon Place, LONDON, WC1H 9BB, United Kingdom. The company can be reached via phone at +44-20-70432116.

MarketBeat Community Rating for Proteome Sciences (LON PRM)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  108 (Vote Outperform)
Underperform Votes:  179 (Vote Underperform)
Total Votes:  287
MarketBeat's community ratings are surveys of what our community members think about Proteome Sciences and other stocks. Vote "Outperform" if you believe PRM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel